Tag: mylan

Zim among top priority lenacapavir recipients as Gilead licenses Hetero

Kuda Pembere

By Kuda Pembere With Zimbabwe being among the 18 top-priority recipients of lenacapavir an HIV preventive drug pending local medicines regulatory approvals, Gilead Sciences, the principal maker has granted a non-exclusive license to leading India headquartered pharmaceutical manufacturer Hetero Group of Companies to manufacture and supply the drug. Gilead’s decision comes following much advocacy by AVAC to give non-exclusive licenses for the manufacturing of lenapavir. The partnership will broaden access to this novel HIV treatment usable in combination with other antiretrovirals while supporting efforts to prevent HIV through pre-exposure prophylaxis…

Read More

Antiretroviral drug called TLE400 saves Zim $ 3, 6 million

Healthtimes

By Kudakwashe Pembere A first line regimen for HIV/AIDS treatment in Zimbabwe  called TLE 400 saved the country $3, 6 million this year alone. The treatment proving to be a ‘wonder’ drug miraculously reducing side effects along with a significant spend was launched yesterday in Harare. The drug funded by the Bill and Melinda Gates Foundation was made by one of the world’s leading global pharmaceutical companies called Mylan. On March 10, 2017, Mylan received tentative approval from the U.S. FDA under PEPFAR for its New Drug Application for the…

Read More